Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma, HCPs, and organizations looking to thrive in the digital age...
Read MoreTop Stories
Cactus Life Sciences Announces the Acquisition
FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus...
Cactus Life Sciences Appoints Oliver Dennis to
Princeton, NJ, April 16, 2024 - Cactus Life Sciences, a...
Optimizing Medical Affairs with Modular Content:
Turn your organization into an “efficiency powerhouse” with...
Filter
What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...
Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation
Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...
Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)
Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
From Transactional to Transformational: Bringing Patient Centricity to the Next Level
The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...
Racial and Ethnic Diversity in Pharma and Clinical Trials
CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this...
The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry
To learn how much businesses can gain from more diverse and inclusive workplaces and why...